Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-013515
Filing Date
2021-07-15
Accepted
2021-07-15 17:36:52
Documents
2
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 10388
2 laurapoa.htm EX-24 9003
  Complete submission text file 0001567619-21-013515.txt   20792
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080 650 325 5156
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMAGO BIOSCIENCES, INC. 329 OYSTER POINT BLVD. 3RD FL SOUTH SAN FRANCISCO CA 94080
Business Address
Eichorn Laura G. (Reporting) CIK: 0001861067 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40604 | Film No.: 211093537